Eli Lilly to acquire Morphic in $3.2B deal

Yahoo Finance Video
28,353 次觀看・4 個月前

Pharmaceutical giant Eli Lilly (LLY) has reached an agreement to purchase biopharmaceutical company Morphic (MORF) in a deal valued at $3.2 billion. This strategic move marks a notable expansion in Eli Lilly's portfolio and research capabilities.

Yahoo Finance health reporter Anjalee Khemlani explores the benefits of this deal for both companies and the broader pharmaceutical industry.

For more expert insight and the latest market action, click here to watch this full episode of Morning Brief.

This article was written by Angel Smith